Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jaguar Health (JAGX) Accounts Payables (2016 - 2025)

Jaguar Health (JAGX) has disclosed Accounts Payables for 11 consecutive years, with $8.4 million as the latest value for Q3 2025.

  • On a quarterly basis, Accounts Payables rose 85.48% to $8.4 million in Q3 2025 year-over-year; TTM through Sep 2025 was $8.4 million, a 85.48% increase, with the full-year FY2024 number at $5.3 million, up 6.27% from a year prior.
  • Accounts Payables was $8.4 million for Q3 2025 at Jaguar Health, up from $6.6 million in the prior quarter.
  • In the past five years, Accounts Payables ranged from a high of $8.4 million in Q3 2025 to a low of $3.3 million in Q1 2024.
  • A 5-year average of $5.2 million and a median of $5.0 million in 2023 define the central range for Accounts Payables.
  • Peak YoY movement for Accounts Payables: crashed 41.67% in 2024, then soared 111.69% in 2025.
  • Jaguar Health's Accounts Payables stood at $4.9 million in 2021, then increased by 17.83% to $5.8 million in 2022, then decreased by 14.36% to $5.0 million in 2023, then increased by 6.27% to $5.3 million in 2024, then soared by 59.72% to $8.4 million in 2025.
  • Per Business Quant, the three most recent readings for JAGX's Accounts Payables are $8.4 million (Q3 2025), $6.6 million (Q2 2025), and $7.0 million (Q1 2025).